Company Filing History:
Years Active: 2012-2015
Title: The Innovative Mind of Benjamin James Boyd
Introduction
Benjamin James Boyd, based in Warrandyte, Australia, is an accomplished inventor with a remarkable portfolio of six patents. His contributions to the field of drug delivery systems and pharmaceutical formulations underscore his commitment to advancing medical technologies.
Latest Patents
Boyd's latest patents showcase his expertise in developing innovative pharmaceutical solutions. One such patent focuses on an anaesthetic formulation that involves a drug delivery system for neuroactive steroid anaesthetic agents. This formulation comprises host/guest preparations that utilize cyclodextrins, particularly sulfoalkyl ether cyclodextrins, enhancing the stability and effectiveness of the anaesthetics used in clinical settings.
Another notable patent relates to a modified macromolecule characterized by controlled terminal group stoichiometry. This innovative design includes a surface layer and at least one subsurface layer, with terminal groups that may comprise a residue of a pharmaceutically active agent and a second group aimed at modifying the pharmacokinetics of the involved substances. These advancements have meaningful implications for drug efficiency and patient care.
Career Highlights
Throughout his career, Benjamin has made significant strides in pharmaceutical innovation while working with prominent companies such as Starpharma Pty Limited and Drawbridge Pharmaceuticals Pty Ltd. His work has positioned him as a valuable asset in the realm of medical research and development.
Collaborations
Collaboration has played a vital role in Boyd's success. He has worked alongside esteemed colleagues such as Guy Yeoman Krippner and Pasquale Razzino. Together, they have contributed to advancing research and innovative solutions within the pharmaceutical industry.
Conclusion
Benjamin James Boyd exemplifies the spirit of innovation and dedication within the field of pharmaceutical research. With his impressive number of patents and collaborative spirit, Boyd continues to pave the way for advancements that may significantly impact the medical community and improve patient outcomes. His work exemplifies the commitment needed to push the boundaries of science and technology in drug delivery systems.